01 1Eli Lilly and Company
01 1Insulin human (recombinant)
01 1U.S.A
Insulin Human (Genetical Recombinant)
Registration Number : 227MF10167
Registrant's Address : Lilly Corporate Center, Indianapolis, Indiana 46285, USA
Initial Date of Registration : 2015-06-18
Latest Date of Registration : 2021-03-05
85
PharmaCompass offers a list of Insulin (Human) Recombinant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Insulin (Human) Recombinant manufacturer or Insulin (Human) Recombinant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Insulin (Human) Recombinant manufacturer or Insulin (Human) Recombinant supplier.
PharmaCompass also assists you with knowing the Insulin (Human) Recombinant API Price utilized in the formulation of products. Insulin (Human) Recombinant API Price is not always fixed or binding as the Insulin (Human) Recombinant Price is obtained through a variety of data sources. The Insulin (Human) Recombinant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Insulin (Human) Recombinant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Insulin (Human) Recombinant, including repackagers and relabelers. The FDA regulates Insulin (Human) Recombinant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Insulin (Human) Recombinant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Insulin (Human) Recombinant supplier is an individual or a company that provides Insulin (Human) Recombinant active pharmaceutical ingredient (API) or Insulin (Human) Recombinant finished formulations upon request. The Insulin (Human) Recombinant suppliers may include Insulin (Human) Recombinant API manufacturers, exporters, distributors and traders.
click here to find a list of Insulin (Human) Recombinant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Insulin (Human) Recombinant Drug Master File in Japan (Insulin (Human) Recombinant JDMF) empowers Insulin (Human) Recombinant API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Insulin (Human) Recombinant JDMF during the approval evaluation for pharmaceutical products. At the time of Insulin (Human) Recombinant JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Insulin (Human) Recombinant suppliers with JDMF on PharmaCompass.
We have 1 companies offering Insulin (Human) Recombinant
Get in contact with the supplier of your choice:
